Compare ORIC & PHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ORIC | PHK |
|---|---|---|
| Founded | 2014 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 837.3M | 861.0M |
| IPO Year | 2020 | N/A |
| Metric | ORIC | PHK |
|---|---|---|
| Price | $8.42 | $4.58 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $19.73 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 604.9K |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.61% |
| EPS Growth | ★ 19.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.65 | $4.41 |
| 52 Week High | $14.93 | $5.04 |
| Indicator | ORIC | PHK |
|---|---|---|
| Relative Strength Index (RSI) | 33.01 | 38.71 |
| Support Level | $7.90 | $4.41 |
| Resistance Level | $13.89 | $4.74 |
| Average True Range (ATR) | 0.50 | 0.05 |
| MACD | -0.10 | -0.01 |
| Stochastic Oscillator | 1.38 | 20.45 |
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
PIMCO High Income Fund is a closed-end management investment company. The company's primary investment objective is to seek high current income. The secondary objective of the company is to seek capital appreciation.